Docetaxel plus cisplatin and bevacizumab for untreated patients with advanced/metastatic non-squamous non-small-cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group
2013 ◽
Vol 71
(3)
◽
pp. 605-612
◽
Keyword(s):
Phase Ii
◽